Skip to main content
. 2021 Sep 2;6:112. doi: 10.1038/s41541-021-00371-y

Fig. 1. Derivation of JEV vaccine strains.

Fig. 1

The successful SA14-14-2 vaccine strain was derived after multiple attempts to attenuate WT strain SA14. The first of these attempts, Clone12-1-7, was generated by mouse and cell culture passage. It was then UV irradiated to generate SA14-2-8 and further mouse passaged to generate SA14-5-3. Both of these vaccine strains were shown to be overly attenuated in humans so SA14-5-3 was passaged in suckling mice which generated the currently utilized SA14-14-2.